Ceylan, F.; Mehdiyev, M.; Dede, D.Ş.; Efil, S.C.; Tenekeci, A.K.; Bilgin, B.; Yücel, Ş.; Tatlı Doğan, H.; Şendur, M.A.N.; Akıncı, M.B.;
et al. Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer. J. Clin. Med. 2025, 14, 173.
https://doi.org/10.3390/jcm14010173
AMA Style
Ceylan F, Mehdiyev M, Dede DŞ, Efil SC, Tenekeci AK, Bilgin B, Yücel Ş, Tatlı Doğan H, Şendur MAN, Akıncı MB,
et al. Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 2025; 14(1):173.
https://doi.org/10.3390/jcm14010173
Chicago/Turabian Style
Ceylan, Furkan, Mirmehdi Mehdiyev, Didem Şener Dede, Safa Can Efil, Ateş Kutay Tenekeci, Burak Bilgin, Şebnem Yücel, Hayriye Tatlı Doğan, Mehmet Ali Nahit Şendur, Muhammed Bülent Akıncı,
and et al. 2025. "Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer" Journal of Clinical Medicine 14, no. 1: 173.
https://doi.org/10.3390/jcm14010173
APA Style
Ceylan, F., Mehdiyev, M., Dede, D. Ş., Efil, S. C., Tenekeci, A. K., Bilgin, B., Yücel, Ş., Tatlı Doğan, H., Şendur, M. A. N., Akıncı, M. B., Uncu, D., & Yalçın, B.
(2025). Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine, 14(1), 173.
https://doi.org/10.3390/jcm14010173
